Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
» MAKO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

MAKO Guru Trades in Q1 2013

Steven Cohen 2,548 sh (New)
Jim Simons 1,487,600 sh (+362.71%)
Mario Gabelli 244,900 sh (+13.7%)
Manning & Napier Advisors, Inc Sold Out
John Keeley Sold Out
» More
Q2 2013

MAKO Guru Trades in Q2 2013

Steven Cohen 8,200 sh (+221.82%)
Mario Gabelli 299,700 sh (+22.38%)
Jim Simons 708,300 sh (-52.39%)
» More
Q3 2013

MAKO Guru Trades in Q3 2013

Mario Gabelli 706,600 sh (+135.77%)
Steven Cohen Sold Out
Jim Simons Sold Out
» More
Q4 2013

MAKO Guru Trades in Q4 2013

Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MAKO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2013-12-31 Sold Out 0.12%$29.55 - $29.99 $ 29.990%0
Mario Gabelli 2013-09-30 Add 135.77%0.07%$11.61 - $29.5 $ 29.9999%706600
Mario Gabelli 2013-06-30 Add 22.38%$10.33 - $12.81 $ 29.99164%299700
John Keeley 2013-03-31 Sold Out $10.76 - $13.17 $ 29.99155%0
John Burbank 2012-12-31 Sold Out 0.12%$12.09 - $17.78 $ 29.99109%0
John Keeley 2012-12-31 New Buy$12.09 - $17.78 $ 29.99109%75
John Burbank 2012-09-30 New Buy0.12%$12.18 - $26.46 $ 29.9985%150000
Mario Gabelli 2012-09-30 Add 33.68%0.01%$12.18 - $26.46 $ 29.9985%194900
Mario Gabelli 2012-06-30 Add 23.87%0.01%$21.37 - $42.5 $ 29.99-3%145800
Mario Gabelli 2011-09-30 Add 45.31%0.01%$21.41 - $40.48 $ 29.99-9%83700
Mario Gabelli 2011-06-30 New Buy0.01%$23.51 - $34.66 $ 29.997%57600
George Soros 2011-06-30 Sold Out $23.51 - $34.66 $ 29.997%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:4M6.Germany
MAKO Surgical Corporation was incorporated in Delaware in November 2004. The Company is a medical device company that markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures. It offers MAKOplasty, an innovative, restorative surgical solution that enables orthopedic surgeons to consistently, reproducibly and precisely treat patient specific, osteoarthritic disease. The Company currently offers MAKOplasty Partial Knee Arthroplasty, or MAKOplasty PKA, and MAKOplasty Total Hip Arthroplasty, or MAKOplasty THA. MAKOplasty PKA, which requires extraction and replacement of the entire joint, enables resurfacing of one or two specific diseased compartments of the joint, preserving significantly more soft tissue and healthy bone of the knee. MAKOplasty procedures are enabled through its proprietary technology consisting of the components which includes its RIO system, its MAKOplasty applications, and its RESTORIS family of implant systems. The centerpiece of MAKOplasty is the RIO system, its proprietary robotic arm, interactive, orthopedic system, that provides both pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal and accurate implant insertion and alignment. The RIO system consists of two elements: a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The RIO system, version 2.0 of its Tactile Guidance System, or TGS, represents an important expansion from its first generation TGS, enabling and expanding the MAKOplasty PKA application to multicompartmental resurfacing procedures, allowing orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage, unicompartmental degeneration through mid-stage, multicompartmental degeneration with a modular knee implant system, as well as enabling the MAKOplasty THA application. The Company's MAKOplasty PKA application enables surgeons to isolate and resurface just one or two specific diseased compartments of the joint through a minimally invasive incision, preserving significantly more soft tissue and healthy bone of the knee. The MAKOplasty knee resurfacing procedure is performed by the surgeon using the surgical planning and execution software integrated into its patient specific visualization system. The Company's MAKOplasty THA application utilizes the RIO system's tactile, visual and auditory feedback to assist the surgeon in preparing the acetabulum (hip socket) for optimal placement of the acetabular cup implant. The MAKOplasty THA application allows the surgeon to preoperatively plan the placement of the hip implants on a three dimensional image of a pre-operative CT scan. Its RESTORIS family of knee implants is designed to enable minimally invasive restoration of one or two of the diseased compartments of the knee joint. Its RESTORIS family of knee implants for use in si
» More Articles for MAKO

Headlines

Articles On GuruFocus.com
comment on MAKO Mar 06 2013 
comment on MAKO Sep 14 2012 
Companies with Buybacks: ISRG Edition Nov 15 2011 
MAKO Surgical Corp. Reports Operating Results (10-Q) Nov 03 2010 
MAKO Surgical Corp. Reports Operating Results (10-Q) Aug 04 2010 
MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 10,000 Shares Mar 10 2010 
MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 10,000 Shares Jan 14 2010 
MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 2,075 Shares Jan 04 2010 
MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 7,925 Shares Dec 31 2009 
MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 12,000 Shares Dec 16 2009 

More From Other Websites
M&A and IPOs a Theme for Medical Device Sector in 2014 Mar 24 2014
MAKO SURGICAL CORP. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets,... Dec 20 2013
Stryker Completes Acquisition of MAKO Surgical Corp. Dec 17 2013
MAKO SURGICAL CORP. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice... Dec 17 2013
Stryker Completes Acquisition of MAKO Surgical Corp. Dec 17 2013
MAKO SURGICAL CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other... Dec 13 2013
MAKO Surgical Corp. Stockholders Approve Merger With Stryker Corporation Dec 13 2013
MAKO SURGICAL CORP. Files SEC form 8-K, Other Events Nov 27 2013
AQR Capital Management starts new positions in FOXA, MAKO and sells ARO, GHL, PBF, EBIX—13F Flash... Nov 26 2013
AQR Capital Management starts new positions in FOXA, MAKO and sells ARO, GHL, PBF, EBIX—13F Flash... Nov 25 2013
MAKO Surgical Corp. (MAKO) Enters Overbought Territory Nov 20 2013
MAKO SURGICAL CORP. Financials Nov 14 2013
MAKO Sees Broader Loss before Merger Nov 12 2013
MAKO Surgical Corporation (MAKO) Marked As A Barbarian At The Gate Nov 11 2013
MAKO SURGICAL CORP. Files SEC form 10-Q, Quarterly Report Nov 06 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK